NCT03944083

Brief Summary

Studies have shown that children with Attention Deficit Hyperactivity Disorder (ADHD) and emotional dysregulation are characterized by high severity of ADHD, comorbid behavior disorders and increased risk of chronic difficulties. New studies have shown promising results by focusing on improving emotional regulation. We lack knowledge about differences in symptom patterns, stability of symptoms over time, comorbid disorders, neurocognitive functions, knowledge and regulation of emotions, psychosocial risk factors and reactions to stress. Children 6 to 12 years admitted to specialist and diagnosed with ADHD will be recruited. ADHD children with and without emotional dysregulation defined as fullfilling the criteria for the diagnosis Disruptive Mood Dysregulation Disorder (DMDD) with regard to differences in symptom patterns, stability of symptoms over time, comorbid disorders, neurocognitive functions, knowledge and regulation of emotions, psychosocial risk factors and reactions to stress..

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 6, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 9, 2019

Completed
23 days until next milestone

Study Start

First participant enrolled

June 1, 2019

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2021

Completed
Last Updated

May 13, 2019

Status Verified

May 1, 2019

Enrollment Period

2.2 years

First QC Date

May 6, 2019

Last Update Submit

May 9, 2019

Conditions

Outcome Measures

Primary Outcomes (5)

  • Attention Deficit Hyperactivity Disorder-Rating Scale total score

    Symptom score. Measure difference from baseline. Lower score means improvement.

    12 months

  • Disruptive Mood Dysregulation Disorder total symptom questionnaire score

    Symptom score. Symptom score. Measure difference from baseline. Lower score means improvement.

    12 months

  • Number of other comorbid disorders in psychiatric interview

    DSM-5 diagnoses: Types and number of diagnoses. More diagnoses means more complex disorder.

    Baseline

  • Affect recognition total score

    Test from NEPSY II. Comparison With norms. Difference from norm reported.

    Baseline

  • Hair cortisol Level

    Cortisol level over time

    Baseline

Study Arms (1)

ADHD with and without DMDD

ADHD with DMDD versus ADHD without DMDD. Observational study at referral and after 6 and 12 months.

Other: Treatment as usual for ADHD

Interventions

Children are given treatment according to diagnostic conclusion and clinical recommendations.

ADHD with and without DMDD

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Children referred to outpatient psychiatric service

You may qualify if:

  • Referred to outpatient psychiatric service.
  • IQ within normal range.
  • Child and parents: Good enough understanding of Norwegian language to give valid answers in interviews and tests.

You may not qualify if:

  • IQ below normal range.
  • Child and parents: Not good enough understanding of Norwegian language to give valid answers in interviews and tests.
  • Unresolved crisis in the family.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nic Waal's Institute

Oslo, 0801, Norway

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Hair samples analyzed on cortisol.

MeSH Terms

Conditions

Attention Deficit Disorder with Hyperactivity

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental Disorders

Study Officials

  • Pål Zeiner, PhD

    Head of child psychiatric research

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Pål Zeiner, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
12 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Project manager

Study Record Dates

First Submitted

May 6, 2019

First Posted

May 9, 2019

Study Start

June 1, 2019

Primary Completion

August 1, 2021

Study Completion

August 1, 2021

Last Updated

May 13, 2019

Record last verified: 2019-05

Locations